Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 26INDUSTRY 19UNKNOWN 1OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 8Breast Neoplasms 5Triple Negative Breast Neoplasms 3Stomach Neoplasms 1Recurrence 1Nasopharyngeal Neoplasms 1IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Squamous Cell 1Adenocarcinoma 1

Interventions

pegylated granulocyte colony-stimulating factor 1Rituximab 1Platinum 1Paclitaxel 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Recurrence × Paclitaxel × Clear all
NCT03731442 2018-12-12

Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients

ChineseAMS

Phase 3 Recruiting
300 enrolled
Gastrointestinal

Esophageal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡